SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
Date first appeared online 09/07/2019
DOI 10.1007/s13300-019-0657-8
Authors Bain S.
Journal Name Diabetes Therapy
Volume

Documents
  • 51170.pdf , Book, Released under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC).